HFQDX
Price
$8.30
Change
-$0.00 (-0.00%)
Updated
Aug 20 closing price
Net Assets
7.92B
TRWTX
Price
$29.84
Change
+$0.31 (+1.05%)
Updated
Aug 21 closing price
Net Assets
4.41B
Interact to see
Advertisement

HFQDX vs TRWTX

HFQDX vs TRWTX Comparison Chart in %
View a ticker or compare two or three
VS
HFQDX vs. TRWTX commentary
Aug 23, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is HFQDX is a StrongBuy and TRWTX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
HFQDX has more cash in the bank: 7.92B vs. TRWTX (4.41B). HFQDX pays higher dividends than TRWTX: HFQDX (6.09) vs TRWTX (3.32). HFQDX was incepted earlier than TRWTX: HFQDX (9 years) vs TRWTX (34 years). HFQDX (0.85) is less costly to investors than TRWTX (0.76). HFQDX is a more actively managed with annual turnover of: 175.00 vs. TRWTX (13.00). TRWTX has a lower initial minimum investment than HFQDX: TRWTX (0) vs HFQDX (2500). HFQDX annual gain was more profitable for investors over the last year : 25.89 vs. TRWTX (23.42). HFQDX return over 5 years is better than : 78.04 vs. TRWTX (58.53).
HFQDXTRWTXHFQDX / TRWTX
Total Expense Ratio0.850.76112%
Annual Report Gross Expense Ratio0.850.76112%
Fund Existence9 years34 years-
Gain YTD18.60618.554100%
Front LoadN/AN/A-
Min. Initial Investment25000-
Min. Initial Investment IRAN/AN/A-
Net Assets7.92B4.41B180%
Annual Yield % from dividends6.093.32183%
Returns for 1 year25.8923.42111%
Returns for 3 years77.6569.32112%
Returns for 5 years78.0458.53133%
Returns for 10 yearsN/A111.88-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
SBHIX29.210.28
+0.97%
Saratoga Health & Biotechnology I
GQJPX12.860.08
+0.63%
GQG Partners Intl Qual Val Fd Inv
PNOPX129.710.63
+0.49%
Putnam Sustainable Leaders A
GRMAX34.210.15
+0.44%
Nationwide S&P 500 Index A
TNRAX23.070.09
+0.40%
1290 Avantis U.S. Large Cap Growth A